Posted on by Docuneeds

Enhanced Usage of Acetaminophen to Reduce the Dependence on Opioids for Pain Management Drives Growth

[ad_1]

DUBLIN, April 26, 2023 /PRNewswire/ — The “Paracetamol IV Market Research Report by Indication (Pain, Pyrexia/Fever), Application (Non-surgical, Surgical), End-use – Global Forecast 2023-2030” report has been added to  ResearchAndMarkets.com’s offering.

Research and Markets Logo

Research and Markets Logo

The Global Paracetamol IV Market size was estimated at USD 878.46 million in 2022, USD 940.79 million in 2023, and is projected to grow at a CAGR of 7.57% to reach USD 1,575.45 million by 2030.

Market Dynamics

Drivers

  • Growing Prevalence of Indicative Diseases and Conditions

  • Increasing Use of Paracetamol Iv in Relieving Fever in Post-Surgical Procedures

  • Enhanced Usage of Acetaminophen to Reduce the Dependence on Opioids for Pain Management

Restraints

Opportunities

  • Government Initiatives and Rising Research and Development Activities

  • Use of Paracetamol Iv in Combination With Non-Steroidal Anti-Inflammatory Drugs (Nsaid) and Narcotics

Challenges

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

  • Based on Indication, the market is studied across Pain and Pyrexia/Fever.

  • Based on Application, the market is studied across Non-surgical and Surgical.

  • Based on End-use, the market is studied across Clinics and Hospitals.

  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Paracetamol IV Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Paracetamol IV Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Paracetamol IV Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Paracetamol IV Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

The report answers questions such as:

1. What is the market size and forecast of the Global Paracetamol IV Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Paracetamol IV Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Paracetamol IV Market?
4. What is the competitive strategic window for opportunities in the Global Paracetamol IV Market?
5. What are the technology trends and regulatory frameworks in the Global Paracetamol IV Market?
6. What is the market share of the leading vendors in the Global Paracetamol IV Market?
7. What modes and strategic moves are considered suitable for entering the Global Paracetamol IV Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Paracetamol IV Market, by Indication

7. Paracetamol IV Market, by Application

8. Paracetamol IV Market, by End-use

9. Americas Paracetamol IV Market

10. Asia-Pacific Paracetamol IV Market

11. Europe, Middle East & Africa Paracetamol IV Market

12. Competitive Landscape

13. Company Usability Profiles

14. Appendix

Companies Mentioned

  • Aurobindo Pharma Ltd.

  • Biological E. Limited

  • Cfl Pharmaceuticals Limited

  • Changshu Huagang Pharmaceuticals Co., Ltd.

  • Dr. Reddy’s Laboratories Ltd.

  • Geno Pharmaceuticals Private Limited

  • Hebei Jiheng Pharmaceutical Co.,Ltd.

  • Huzhou Konch Pharmaceutical Co., Ltd.

  • Lupin Pharmaceuticals, Inc.

  • Mallinckrodt PLC

  • Novartis AG

  • Sanofi S.A.

  • Sun Pharmaceutical Industries Limited

  • Teva Pharmaceutical Industries Ltd.

  • Zhejiang Kangle Pharmaceutical Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/lf0e7s

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

Cision

Cision

View original content:https://www.prnewswire.com/news-releases/paracetamol-iv-global-market-report-2023-enhanced-usage-of-acetaminophen-to-reduce-the-dependence-on-opioids-for-pain-management-drives-growth-301808318.html

SOURCE Research and Markets

[ad_2]

Source link